Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Picozzi

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|April 8, 2017
Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyFrancesca Maria Carozzi, Simonetta Bisanzi, Laura Carrozzi, et al.
European Radiology|March 1, 2023
Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trialMario Mascalchi, Chiara Romei, Chiara Marzi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factorsDonella Puliti, Mario Mascalchi, Francesca Maria Carozzi, et al.
European Journal of Radiology|August 20, 2024
Large cell carcinoma of the lung: LDCT features and survival in screen-detected casesMario Mascalchi, Donella Puliti, Edoardo Cavigli, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be AddressedMario Mascalchi, Giulia Picozzi, Donella Puliti, et al.
Cancer Communications (London, England)|February 26, 2026
Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLSTRudolf Kaaks, Francisco Omar Cortés-Ibáñez, Stefan Delorme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2013
Four-year results of low-dose CT screening and nodule management in the ITALUNG trialAndrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, et al.
European Journal of Radiology|November 23, 2021
Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: The ITALUNG trialMario Mascalchi, Donella Puliti, Chiara Romei, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2009
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosisFrancesca Maria Carozzi, Simonetta Bisanzi, Patrizia Falini, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|April 8, 2017
Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyFrancesca Maria Carozzi, Simonetta Bisanzi, Laura Carrozzi, et al.
European Radiology|March 1, 2023
Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trialMario Mascalchi, Chiara Romei, Chiara Marzi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factorsDonella Puliti, Mario Mascalchi, Francesca Maria Carozzi, et al.
European Journal of Radiology|August 20, 2024
Large cell carcinoma of the lung: LDCT features and survival in screen-detected casesMario Mascalchi, Donella Puliti, Edoardo Cavigli, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be AddressedMario Mascalchi, Giulia Picozzi, Donella Puliti, et al.
Cancer Communications (London, England)|February 26, 2026
Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLSTRudolf Kaaks, Francisco Omar Cortés-Ibáñez, Stefan Delorme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2013
Four-year results of low-dose CT screening and nodule management in the ITALUNG trialAndrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, et al.
European Journal of Radiology|November 23, 2021
Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: The ITALUNG trialMario Mascalchi, Donella Puliti, Chiara Romei, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2009
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosisFrancesca Maria Carozzi, Simonetta Bisanzi, Patrizia Falini, et al.
Pageof 4